Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Organon & Co. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 741 | 10 | 722 | −9 |
| Shares | 205.7M | 572.2K | 202.9M | −2.24M (−1.1%) |
| Value | $3.07B | $8.54M | $3.01B | −$51.9M (−1.7%) |
10 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (84)
Institutions that held Organon & Co. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (93)
Institutions that held Organon & Co. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (10)
Institutions that held Organon & Co. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 513,828 | $7.67M |
| River & Mercantile Asset Management LLP | 33,084 | $493.8K |
| Vise Technologies, Inc. | 15,944 | $237.9K |
| Global Retirement Partners, LLC | 8,284 | $123.6K |
| Hilltop National Bank | 527 | $7.86K |
| Householder Group Estate & Retirement Specialist, LLC | 337 | $5.00K |
| Oliver Lagore Vanvalin Investment Group | 92 | $1.37K |
| Cassady Schiller Wealth Management, LLC | 63 | $940 |
| Sugarloaf Wealth Management, LLC | 18 | $272 |
| Northwest Bank & Trust Co | 6 | $95 |